Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria (eGFR)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Hospital Authority, Hong Kong
ClinicalTrials.gov Identifier:
NCT01500590
First received: December 23, 2011
Last updated: October 22, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2017
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)